Isorod PD-103 Implant, Model ATI-PD-103
Source, Brachytherapy, Radionuclide. 510(k) K020683, from Ati Medical, Inc. (San Diego, CA). Product code KXK, class 2.
As of Nov 21, 2026, K020683 is an FDA 510(k) held by Ati Medical, Inc., substantially equivalent on Dec 17, 2002 after 288 days, with no recalls tied to it in FDA's recall database.
- Review time: 288 days
- Recalls: 0
The ATI Medical, Inc. IsoRod Pd-103 Radionuclide Brachytherapy Source is intended for permanent interstitial implantation for the treatment of selected localized tumors with low to moderate radiosensitivity.
- GenetraK013660 · Radiomed Corporation · Dec 5, 2001
- Theraseed(R) Palladium-103 Implant; Model 200K010283 · Theragenics Corp. · Apr 26, 2001
- IntersourceK973328 · International Brachytherapy S.A. · Dec 10, 1998
- OncoPatchK252296 · Oncopatch, Inc. · Dec 5, 2025
- IsoSphereK242818 · Isoaid, LLC · Jul 15, 2025
- RadianceTx Radionuclide Brachytherapy SourceK223465 · Radiance Therapeutics, Inc. · Jan 11, 2023
- GammaTileK221539 · Gt Medical Technologies · Nov 9, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Mar 4, 2002
- Review panel
- Radiology
- Regulation
- 21 CFR 892.5730
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files